Fairscale Capital »

Amgen shares owned by Fairscale Capital

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $309k 959 322.21
2024-06-30 $320k 959 333.14

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
iShares S&P NA Tech. Sec. Idx (IGM)
NVIDIA Corporation (NVDA)
Vanguard Admiral Fds Inc equity (VOOV)
Apple (AAPL)
Pacer Fds Tr us cash cows 100 (COWZ)
Microsoft Corporation (MSFT)
Invesco Qqq Trust Series 1 (QQQ)
Visa (V)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Schwab Strategic Tr us dividend eq (SCHD)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Facebook Inc cl a (META)

View all positions for Fairscale Capital

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
Morgan Stanley
PRIMECAP Management Company
Geode Capital Management
Charles Schwab Investment Management
Wells Fargo & Company
Bank of America Corporation
Goldman Sachs Group
Bank of New York Mellon
Royal Bank of Canada
Henderson Group
T. Rowe Price Associates
Reed Conner & Birdwell

View all funds holding Amgen